| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...752167C |
| P356 | DOI | 10.1371/JOURNAL.PONE.0052167 |
| P932 | PMC publication ID | 3524112 |
| P698 | PubMed publication ID | 23284920 |
| P5875 | ResearchGate publication ID | 234043757 |
| P2093 | author name string | David J Picketts | |
| Robin J Parks | |||
| Emma Goodall | |||
| Damiano Conte | |||
| Marilyne Delorme | |||
| Michael Huh | |||
| P2860 | cites work | Alpha thalassaemia-mental retardation, X linked | Q21203051 |
| Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes | Q22010822 | ||
| Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association | Q22253267 | ||
| Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation | Q22253401 | ||
| Nuclear structure in normal and Bloom syndrome cells | Q22253976 | ||
| Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres | Q24292850 | ||
| Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation | Q24296972 | ||
| Critical role for Daxx in regulating Mdm2 | Q24297332 | ||
| The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9 | Q24297608 | ||
| Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome) | Q24311995 | ||
| The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3 | Q24315621 | ||
| Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: implication for genomic instability in human diseases | Q24317166 | ||
| The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies | Q24319767 | ||
| Interaction of human recombination proteins Rad51 and Rad54 | Q24545517 | ||
| The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis | Q24557516 | ||
| Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin | Q27670415 | ||
| ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome | Q27670417 | ||
| ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells | Q28114801 | ||
| 5-Fluorouracil: mechanisms of action and clinical strategies | Q28201937 | ||
| Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein | Q28264443 | ||
| Distinct factors control histone variant H3.3 localization at specific genomic regions | Q28275277 | ||
| Mutations in the chromatin-associated protein ATRX. | Q51891945 | ||
| Patient mutations alter ATRX targeting to PML nuclear bodies. | Q51898063 | ||
| Chromosomal breaks during mitotic catastrophe trigger γH2AX-ATM-p53-mediated apoptosis. | Q53222824 | ||
| Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. | Q53559996 | ||
| MyoD is required for myogenic stem cell function in adult skeletal muscle | Q71172968 | ||
| DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors | Q28303693 | ||
| Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome | Q28304264 | ||
| Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene | Q28505487 | ||
| Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome | Q28508472 | ||
| A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity | Q28589633 | ||
| Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma | Q29616862 | ||
| Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions | Q29618531 | ||
| Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues | Q33240549 | ||
| Loss of ATRX in chondrocytes has minimal effects on skeletal development | Q33506092 | ||
| Altered telomeres in tumors with ATRX and DAXX mutations | Q34196696 | ||
| Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway | Q34350929 | ||
| Toll receptors, CD14, and macrophage activation and deactivation by LPS. | Q34727357 | ||
| Strand pairing by Rad54 and Rad51 is enhanced by chromatin | Q35804759 | ||
| Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression | Q35843809 | ||
| A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal | Q35915922 | ||
| Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas | Q36236484 | ||
| HP1-beta is required for development of the cerebral neocortex and neuromuscular junctions | Q36972650 | ||
| Acquired somatic ATRX mutations in myelodysplastic syndrome associated with α thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations | Q38450295 | ||
| Construction and characterization of adenovirus vectors | Q39741237 | ||
| Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors | Q40582642 | ||
| A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein | Q40584630 | ||
| Cancer therapy utilizing an adenoviral vector expressing only E1A. | Q40737438 | ||
| Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation | Q40959743 | ||
| Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors | Q41102151 | ||
| Loss of ATRX leads to chromosome cohesion and congression defects | Q41825660 | ||
| Neuronal death resulting from targeted disruption of the Snf2 protein ATRX is mediated by p53. | Q41938609 | ||
| Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival | Q43181903 | ||
| Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations | Q44269667 | ||
| Rad54p is a chromatin remodeling enzyme required for heteroduplex DNA joint formation with chromatin | Q44270140 | ||
| Expression of macrophage CD44 receptor in the course of experimental inflammatory response of bovine mammary gland induced by lipopolysaccharide and muramyl dipeptide | Q46386732 | ||
| dXNP, a Drosophila homolog of XNP/ATRX, induces apoptosis via Jun-N-terminal kinase activation | Q47072310 | ||
| ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. | Q47407852 | ||
| dXNP/DATRX increases apoptosis via the JNK and dFOXO pathway in Drosophila neurons | Q47908812 | ||
| Comparison of the human and murine ATRX gene identifies highly conserved, functionally important domains | Q48038450 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e52167 | |
| P577 | publication date | 2012-12-17 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Loss of Atrx sensitizes cells to DNA damaging agents through p53-mediated death pathways | |
| P478 | volume | 7 |
| Q39071428 | ATRX and DAXX: Mechanisms and Mutations |
| Q90346173 | Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks |
| Q52657331 | Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling. |
| Q26740256 | DNA repair mechanisms and their clinical impact in glioblastoma |
| Q92367904 | Expression and prognostic impact of alpha thalassemia/mental retardation X-linked and death domain-associated protein in human lung cancer |
| Q91905154 | Glial ensheathment of the somatodendritic compartment regulates sensory neuron structure and activity |
| Q34490850 | Histone variant H3.3 provides the heterochromatic H3 lysine 9 tri-methylation mark at telomeres |
| Q49719068 | Inferences of individual drug responses across diverse cancer types using a novel competing endogenous RNA network |
| Q36873846 | Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma |
| Q55456861 | Mutant ATRX: uncovering a new therapeutic target for glioma. |
| Q45999303 | Prospective feasibility trial for genomics-informed treatment in recurrent and progressive glioblastoma. |
| Q89634172 | The Personalisation of Glioblastoma Treatment Using Whole Exome Sequencing: A Pilot Study |
| Q42369808 | The Role of ATRX in Glioma Biology |
| Q38454659 | Toward precision medicine in glioblastoma: the promise and the challenges |
| Q36008475 | Unbiased phosphoproteomic method identifies the initial effects of a methacrylic acid copolymer on macrophages |
Search more.